Perforin is a major contributor to NK cell control of tumor metastasis

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6658-6662

  Smyth, Mark J ^a   Thia, Kevin Y T ^a   Cretney, Erika ^a   Kelly, Janice M ^a   Snook, Marie B ^a   Forbes, Catherine A ^b   Scalzo, Anthony A ^b  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOTOXICITY; EFFECTOR CELL; METASTASIS; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS; ANTIGENS, SURFACE; CARCINOMA; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PORE FORMING CYTOTOXIC PROTEINS; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033152840     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fidler, I. J., D. M. Gersten, and C. W. Riggs. 1977. Relationship of host immune status to tumor celt arrest, distribution, and survival in experimental metastasis. Cancer 40:46.
2. Wiltrout, R. H., P. Frost, M. K. Morrison, and R. S. Kerbel. 1979. Immunemediated arrest and reversal of established visceral metastases in athymic mice. Cancer Res. 39:4034.
3. Mazumder, A., and S. A. Rosenberg. 1984. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2. J. Exp. Med. 159:495.
4. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
5. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 369:31.
6. van den Broek, M. F., D. Kagi, R. M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514.
7. van den Broek, M. F., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. M. Melief, R. M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781.
8. Smyth, M. J., J. M. Kelly, A. G. Baxter, H. Korner, and J. D. Sedgwick. 1998. An essential role for tumor necrosis factor in NK cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611.
9. Riccardi, C., A. Santoni, T. Barlozzari, P. Puccetti, and R. B. Herberman. 1980. In vivo natural reactivity of mice against tumor cells. Int. J. Cancer 25:475.
10. M1-treated rats. J. Immunol. 131:1024.
11. Whiteside, T. L., and R. B. Herberman. 1995. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7:704.
12. Basse, P., R. B. Herberman, U. Nannmark, B. R. Johansson, M. Hokland, K. Wasserman, and R. H. Goldfarb. 1991. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J. Exp. Med. 174:479.
13. Hall, S. J., M. A. Sanford, G. Atkinson, and S. H. Chen. 1998. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res. 58:3221.
14. Kagi, D., B. Ledermann, K. Burki, P. Seller, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
15. Forbes, C. A., M. G. Brown, R. Cho, G. R. Shellam, W. M. Yokoyama, and A. A. Scalzo. 1997. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family with the natural killer cell gene complex on mouse chromosome 6. Genomics 41:406.
16. Spanopoulou, E., C. A. Roman, L. M. Corcoran, M. S. Schlissel, D. P. Silver, D. Nemazee, M. C. Nussenzweig, S. A. Shinton, R. R. Hardy, and D. Baltimore. 1994. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev. 8:1030.
17. Ljunggren, H. G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162: 1745.
18. Katz, B. Z., R. Eshel, O. Sagi-Assif, and I. P. Witz. 1994. An association between high Ly-6A/E expression on tumor cells and a highly malignant phenotype. Int. J. Cancer 59:684.
19. Thompson, T. C., J. Southgate, G. Kitchener, and H. Land. 1989. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56:917.
20. Smyth, M. J., K. Y. T. Thia, and M. H. Kershaw. 1997. Xenogeneic mouse anti-human NK Cytotoxicity is mediated via perform. Xenotransplantation 4:78.
21. Eastham, J. A., S. H. Chen, I. Sehgal, G. Yang, T. L. Timme, S. J. Hall, S. L. Woo, and T. C. Thompson. 1996. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum. Gene Ther. 7:515.
22. Smyth, M. J., M. H. Kershaw, and J. A. Trapani. 1997. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo. Transplantation 63:1171.
23. Hall, S. J., S. E. Mutchnik, S. H. Chen, S. L. Woo, and T. C. Thompson. 1997. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer. Int. J. Cancer 70:183.
24. Oshimi, Y., S. Oda, Y. Honda, S. Nagata, and S. Miyazaki. 1996. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:2909.
25. Zamai, L., M. Ahmad, I. M. Bennett, L. Azzoni, E. S. Alnemri, and B. Perussia. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:2375.
26. Tay, C. H., and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71: 267.
27. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
28. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J. Immunol. 156:3366.
29. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
30. Eberl, G., and H. R. MacDonald. 1998. Rapid death and regeneration of NKT cells in anti-CD3ε-or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9:345.